APOE and Alzheimer disease: This is consistent with previous reports that APOE4 affects AD-related biomarkers in an E4 allele dose-dependent effect which varies by sex (Farrer et al., 1997; Mortensen and Hogh, 2001; Beydoun et al., 2012).